FDA Import Refusal AEK-2087812-9/10003/1 — TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS — FEI 3031966206

The FDA refused shipment AEK-2087812-9/10003/1 from TORRENT PHARMACEUTICALS (India) on Sep 30, 2026. The refused product falls under Drugs and Biologics — DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Sep 30, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61LCY41 DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT)
Charges
75